High Aluminum Content in Infant Formulas

formulaAccording to UNICEF, over 130 million babies are born each year worldwide, which means all those parents must start caring for their new children. The most basic care of a newborn involves the nutrition it receives in the form of breast milk or baby formula. While the numbers are not concrete, we can safely estimate that there are millions of infants who receive formula instead of natural breast milk. With that being said, can every caregiver trust the formula?

Infant formula is specifically constructed with ingredients that are essential for healthy development; however, some ingredients have made their way into some formulas which aren’t essential for development. Dr. Christopher Exley, a funded CMSRI researcher, found aluminum in both ready-to-drink milks and milk powders across 30 different infant formula products. While at first this may not seem unsettling, aluminum is a non-essential metal in the body and is consider a neurotoxic. So why is aluminum an ingredient in baby formula?

{Read The Full Study Here}

Some research has already suggested that aluminum can pose chronic health risks and is typically found in numerous vaccines. Studies have pointed out strong evidence that aluminum disrupts neurological development leading to conditions like Autism, Crohns Disease and even some cancers. Dr. Exley collected 30 samples of infant formula that can be regularly purchased from retailers in the UK. During the study, each sample was stored according to the manufacturers’ instruction and was tested immediately upon opening.

What raises concern is the amount of concentrated aluminum found in the formulas. According to European Union standards, drinking water may have up to 50 μg/L of concentrated aluminum and all 30 samples of infant formula had at least double the amount of concentrated aluminum in their servings. This raises concern over the health risks newborns are exposed to when consuming such formulas. Children, especially infants, are extremely sensitive to foreign chemicals and ingredients in their bodies and knowing that aluminum is a neurotoxic, it could potentially cause health problems.

Taking the 30 samples of infant formula and their results, it should raise awareness to the public that manufacturers are potentially causing ill effects to their children. This should call to action legislation, regulatory mandates and consumer advocacy campaigns to reduce the amount of aluminum found in infant formula.

Read More

Children At Risk: Aluminum Adjuvants

With over 80 years of use, the safety of aluminum adjuvants used in vaccines continues to rest on assumptions rather than scientific evidence. To date, a minimal amount of scientific evidence or research has been conducted regarding the safety of vaccines and the ingredients that come with them. That being said, recent research has shown pediatric populations suffer from unknown adverse reactions that stem from the toxicity of aluminum adjuvants.

Evidence that is available draws the conclusion that long-term persistence of aluminum adjuvants in adults can lead to cognitive dysfunction and autoimmunity. This raises the question – how does its use affect developing children? Since children and adults receive the same vaccines with the same dosage, children continue to be regularly exposed to much higher levels of aluminum adjuvants than adults because of their smaller and unique body structure.

Christopher Shaw and Lucija Tomljenovic are funded researchers of Children’s Medical Safety Research Institute and have drawn concerns regarding the use of neurotoxic substances such as aluminum as an adjuvant in pediatric vaccine formulations. The researchers urge that infants and young children should not be considered “small adults” when it comes to toxicological risks. The use of the same vaccinations should cease because children are not fully developed. The inherent risks pose developmental concerns when injecting the aluminum adjuvants because it can manipulate the autoimmune system in negative ways.

They suggest that aluminum vaccines cause multifactorial stimulatory effects on the immune system that can result in antigenic compounds failure to launch adequate immune responses. Also, during prenatal and early postnatal development, the brain is extremely vulnerable to neurotoxic insults. The development is highly sensitive and exposure to the neurotoxins will have a permeable impact to vital living functions. In addition to the early developmental stages of children and infants, ‘the immature renal system of the neonates significantly compromises their ability to eliminate environmental toxicants.’

This research should be enough evidence that children are at a higher risk of adverse reactions from aluminum adjuvants than adults. Infants and children have a unique physiology compared to adults that makes them much more vulnerable to noxious environmental insults.

Read More

George Mason University Appoints Claire Dwoskin

Claire Dwoskin was appointed to the Board of Visitors at George Mason University in the beginning of June. The university is located in Fairfax, Virginia which holds a 16 member board that exercises its authority principally in policy-making and oversight.

Dwoskin, alongside three other new appointees, will serve a four-year term starting July 1, 2014 and ending June 30, 2018. The 16 members are appointed by the Governor of Virginia, Gov. Terry McAuliffe, and serve on a rotating basis. These members are the corporate and governing body of the university that work under the leadership of a rector, vice rector and secretary.

Some of the duties Dwoskin will be responsible for include setting tuition rates, approving the university’s budget and appointing the university president. Currently, George Mason University is home to approximately 21,000 undergraduate students and 12,000 graduate students.

The Board of Visitors was established at the university in April 1972 when the school became an independent institution and has since assisted with the operations of the university. Meetings of the Board of Visitors and its committees are open to the public, except in the case of executive sessions.

With Dwoskin’s background in funding scientific research into chronic health conditions among young children and the elderly, she may be able to provide guidance on the importance of academic research as both a stimulant to economic growth and as an important factor in understanding societal and economic trends. Her family foundation has funded highly accessed research through Children’s Medical Safety Research Institute. Specifically, CMSRI is funding research into the causal factors underlying the increases in the prevalence of previously rare disorders that are becoming more frequent, such as serious autoimmune health conditions and age related disorders in the nervous system.

CMSRI is focused on discovering changes in human exposures which may be a leading cause to chronic health conditions like immune, inflammatory and cognitive disorders in children and adults ranging from asthma to neurodevelopmental disorders. Understanding the root causes is the key to preventing these conditions, as well as in developing more effective treatments and cures. Knowledge obtained through academic research funded by her foundation will likely spark new medical and therapeutic advances as well as reduce costs associated with conditions that can be prevented.

A vast amount of research has been conducted regarding the use of vaccines and their effects on the body because it is believed that some ingredients spur adverse reactions. One ingredient used in many vaccines is aluminum – which, when used as an adjuvant, has the potential to be toxic and harmful to every organ system in the body. Ms. Dwoskin will continue to support CMSRI while fulfilling board duties at George Mason University.

Read More

1 in 2 Children May Suffer From Neurological Disorder by 2025

Claire Dwoskin and Dr. Stephanie Seneff were interviewed by Leslie Carol Botha, an internationally recognized expert on women’s hormone health, to discuss the prominent issues regarding vaccinations.

Dwoskin and Dr. Seneff were in attendance at the “AutismOne: The Cutting Edge Conference” in Chicago that was held on May 21-25, 2014. The annual conference helps medical consumers become more informed on autism science and treatment which were discussed by over 100 leading scientists, experts and doctors. The conference was attended by about 1200 people, seeking educational information about autism and the latest scientific research to help them understand this neurological and immune epidemic affecting children around the world, with the highest rates being found in the United States.

AutismOne invited parents to be a part of the “Healing Autism” movement to help their children by listening to the presented findings in the conference.

Dwoskin and Dr. Seneff addressed the acknowledged increases in autoimmune and autoinflammatory conditions among young children and the elderly. Botha mentioned that she chose not to vaccinate her children upon meeting two children, 35 years ago, that were quadriplegics. Their injuries were a result of vaccinations. She mentioned that because of the concerns with unknown risks that vaccines carry with them, and the lack of information about how vaccines impact health, she became involved in the issue of vaccine safety despite not having a children affected by autism.

Dwoskin is a firm believer that funding research is playing an important role in discovering the link between adverse health conditions and vaccines. With her family foundation’s backing, researchers have discovered new information relating to the rise in chronic neurological and autoimmune conditions after vaccination. Chronic illnesses and disabilities are growing in young and elderly populations. Compared to infectious diseases, chronic health conditions are far more prevalent and costly to the US healthcare system. Finding a solution to this problem is a goal of the Dwoskin Foundation, as well as to further educate the public on vaccination injuries and adverse health consequences.

Dwoskin explains that her involvement began when one of her children suffered a vaccine injury. This injury required numerous visits for occupational therapy, vision therapy, auditory processing therapy and speech and language therapy.  Dwoskin observed many other children with a wide array of impairments while in the waiting rooms, which sparked her drive to broaden the available scientific knowledge on vaccine safety. She saw a big gap in the knowledge and science of how vaccines affect children’s overall health, which is how her family foundation began to fund research into this growing problem.

Dr. Seneff and Dwoskin want to find out the causal factors behind this growing epidemic so that scientists and clinicians can work together to prevent vaccine injuries and illnesses from occurring and develop more effective treatments and cures.  They both are concerned with the current medical model that focuses on treating symptoms rather than identifying root causes and prevention.

A main topic of discussion was the 1 in 2 (children) statistic, which as it stands now, represents the number of children diagnosed with some type of chronic health condition such as ADD, ADHD, allergies, asthma and obesity. Alarmingly, 1 in 2 will be diagnosed with a neurological disorder such as autism by 2025 if current trends continue and preventive measures are not taken. Currently in 2014, about 1 in 50 are diagnosed with autism spectrum disorder.

To listen to the full interview, visit Botha’s website where Dwoskin and Dr. Seneff discuss the details of their research.

Read More

Supporting Ground Breaking Research Achieves Results

The mission of the Dwoskin Family Foundation has always been focused on children’s health, scientific research and raising awareness of adverse reactions to vaccines. The foundation was co-founded by Claire Dwoskin, a child health activist, sponsor and trailblazer of a global  effort to address the increasing occurrence of  chronic illness and disability, including autoimmunity and age related neurological diseases.

Dwoskin is the founder of Children’s Medical Safety Research Institute (CMSRI) which provides funding for medical and scientific research  on vaccines and their ingredients. Some of the projects the institute has worked on involves the use of aluminum in vaccines. Aluminum is an experimentally demonstrated neurotoxin commonly used in vaccines and it is supposed to act as an exciting agent within the immune system.

The research points out that despite 90 years of widespread use of aluminum adjuvants, the agencies responsible for evaluating the safety of vaccines and their ingredients have not yet developed an adequate understanding about their mechanisms of action.  A significant issue is in the safety of an ingredient that medical science has limited knowledge of, and which  has shown surprisingly dangerous effects on health and ability. This research points out the harm in administering substances to children and adults without utilizing sufficiently rigorous research methods to support the safety of their inclusion in not one, but multiple vaccines administered throughout childhood. Current study designs do not assess vaccines or their ingredients for their cumulative or synergistic biological or genetic effects, or their reactivity with other substances humans are exposed to, such as glyphosate, a chemical in Roundup.

Specifically, aluminum vaccine adjuvants carry risks for autoimmunity, chronic brain inflammation and related neurological complications which may have profound and widespread negative health consequences. The research was conducted by  researchers, Dr. Lucija Tomljenovic,  and Dr. Christopher Shaw, a neuroscientist who are from the University of British Columbia in Canada. Dr. Shaw also serves as chair of the scientific advisory board at CMSRI.

In a previous study completed by Dr. Shaw, aluminum hydroxide injections were linked to motor deficits and motor neuron degeneration. This research was conducted originally to study the effects of aluminum adjuvants in anthrax and other vaccines which were used during the time of the Gulf War. Many veterans suffered from the multi-system disorder called Gulf War Syndrome (GWS). Those affected by GWS showed signs of neurological deficits including various cognitive dysfunctions and motor neuron disease.

The most likely culprit appeared to be aluminum hydroxide per the study’s conclusions, When the aluminum adjuvant was injected into mice, it resulted in motor neuron loss, motor weakness, cognitive impairments and impaired social and emotional behaviors. The mice displayed  comparable neurological deficits, cognitive dysfunctions and motor neuron disease from the same age and weight adjusted doses of aluminum hydroxide that were administered to GWS victims.

The research funded by the Dwoskin Family Foundation and now CMSRI can study vaccines for their potential causal relationships to chronic health problems that are  appearing  with increased frequency after exposure to vaccines and their toxic ingredients. Studying the effects helps  raise awareness and spread information about the harmful and adverse effects aluminum adjuvants and vaccines in general can have on the body.

Read More

CMSRI Funded Researchers Hosted in France

The Dwoskin Family Foundation has been pursuing autoimmune disease research in the area of vaccine safety and advocacy. The efforts to draw international attention and raise awareness to increasing incidences of chronic illnesses and disabilities relating to vaccine injections has been a main priority to the foundation.

In support of such research that provides new information focused around childhood health conditions, the Children’s Medical Safety Research Institute (CMSRI) offers funding to methodologically sound controlled scientific research on vaccines and their ingredients.

Four CMSRI funded researchers were called upon to present at a debate in Paris, France to discuss the lack of safety of vaccines and ingredients. The hearing and press conference is the first time a western governmental authority has called experts to testify about the adverse reactions to vaccines. The vaccine debate was presented in front of French Parliament, French Senate, health authorities, medical professionals and the public.

French government officials had many stakeholders involved at the conference that were for both sides of the debate to keep the discussions fair. There were a number of people who spoke about their adverse events after they were vaccinated; a panel of scientists and medical professionals also were in attendance to present their research regarding unsafe vaccines and ingredients as well as supporters of vaccines.

Four separate round table discussions occurred that were followed by open debates and public questioning. CMSRI funded researchers from around the globe presented various issues to the discussion board.

Professor Romain Gherardi was a part of the first round table and discussed the Bio-persistence and neuro-migration of aluminum adjuvant which is a key ingredient in vaccines. Gherardi, manager of the Center of Muscle Neuropathology at H. Mondor Hospital in France, was able to represent how far our funded research can travel.

Professor Yehuda Shoenfeld joined the first round table and shared findings of the autoimmune and inflammatory syndrome induced by adjuvants. Shoenfeld is the Director of the Center for Autoimmune Diseases at the Sheba Medical Center and Chairman of the 9th International Congress on Autoimmunity in Israel.

Professor Chris Exley, of Keele University in the United Kingdom, presented the toxicity of aluminum in humans in the first round table. During the second round table, Dr. Lucija Tomljenovic, of University of British Columbia located in Canada, went over vaccination against HPV and described the benefit and risk balance.

This was the first open discussion regarding the safety risks by vaccination possibly paving the way for other countries around the world to take a second look. CMSRI continues to discover new elements regarding adverse health conditions and raising awareness to broaden its reach.

Read More